Research Highlights

< Previous         Next >  
Ripoptosome: a novel IAP-regulated cell death-signalling platform Free
Gergely Imre1, Sarit Larisch2, and Krishnaraj Rajalingam1,*
1Institute of Biochemistry II, Goethe University School of Medicine, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany
2Cell Death Research Laboratory, Department of Biology, Faculty of Natural Sciences, University of Haifa, Multi-Purpose Building, Mount Carmel, Haifa 31905, Israel *Correspondence to:Krishnaraj Rajalingam, E-mail: krishna@biochem2.de
J Mol Cell Biol, Volume 3, Issue 6, December 2011, 324-326,  https://doi.org/10.1093/jmcb/mjr034

Recent studies have revealed that cell death stimuli can trigger programmed necrosis, necroptosis. Receptor-interacting serine–threonine kinase family RIP plays a crucial role in regulating the switch between apoptosis and necroptosis. Two studies now describe a novel RIP1 containing ∼2 MDa ‘Ripoptosome’ complex assembled in the cytosol to mediate both apoptosis and necroptosis in response to genotoxic stress and TLR3 stimulation. Intriguingly, cIAPs and XIAP function as endogenous inhibitors of Ripoptosome by direct ubiquitination of its components.